# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001404644-25-000070
Filing Date
2025-06-30
Accepted
2025-06-30 16:02:07
Documents
50
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ngne-20250630.htm iXBRL | 8-K | 28679
2 | EX-99.1 | regupdaterelease.htm | EX-99.1 | 29933
3 | EX-99.2 | a202506_ngnecorporatepre.htm | EX-99.2 | 43393
7 |  | a202506_ngnecorporatepre001.jpg | GRAPHIC | 103634
8 |  | a202506_ngnecorporatepre002.jpg | GRAPHIC | 292992
9 |  | a202506_ngnecorporatepre003.jpg | GRAPHIC | 124041
10 |  | a202506_ngnecorporatepre004.jpg | GRAPHIC | 59734
11 |  | a202506_ngnecorporatepre005.jpg | GRAPHIC | 130437
12 |  | a202506_ngnecorporatepre006.jpg | GRAPHIC | 37907
13 |  | a202506_ngnecorporatepre007.jpg | GRAPHIC | 120012
14 |  | a202506_ngnecorporatepre008.jpg | GRAPHIC | 120915
15 |  | a202506_ngnecorporatepre009.jpg | GRAPHIC | 126592
16 |  | a202506_ngnecorporatepre010.jpg | GRAPHIC | 35990
17 |  | a202506_ngnecorporatepre011.jpg | GRAPHIC | 116877
18 |  | a202506_ngnecorporatepre012.jpg | GRAPHIC | 119840
19 |  | a202506_ngnecorporatepre013.jpg | GRAPHIC | 128686
20 |  | a202506_ngnecorporatepre014.jpg | GRAPHIC | 138150
21 |  | a202506_ngnecorporatepre015.jpg | GRAPHIC | 172363
22 |  | a202506_ngnecorporatepre016.jpg | GRAPHIC | 129711
23 |  | a202506_ngnecorporatepre017.jpg | GRAPHIC | 107093
24 |  | a202506_ngnecorporatepre018.jpg | GRAPHIC | 94131
25 |  | a202506_ngnecorporatepre019.jpg | GRAPHIC | 122251
26 |  | a202506_ngnecorporatepre020.jpg | GRAPHIC | 120967
27 |  | a202506_ngnecorporatepre021.jpg | GRAPHIC | 119239
28 |  | a202506_ngnecorporatepre022.jpg | GRAPHIC | 76751
29 |  | a202506_ngnecorporatepre023.jpg | GRAPHIC | 74237
30 |  | a202506_ngnecorporatepre024.jpg | GRAPHIC | 120499
31 |  | a202506_ngnecorporatepre025.jpg | GRAPHIC | 103532
32 |  | a202506_ngnecorporatepre026.jpg | GRAPHIC | 118030
33 |  | a202506_ngnecorporatepre027.jpg | GRAPHIC | 33822
34 |  | a202506_ngnecorporatepre028.jpg | GRAPHIC | 87699
35 |  | a202506_ngnecorporatepre029.jpg | GRAPHIC | 26267
36 |  | a202506_ngnecorporatepre030.jpg | GRAPHIC | 143302
37 |  | a202506_ngnecorporatepre031.jpg | GRAPHIC | 134778
38 |  | a202506_ngnecorporatepre032.jpg | GRAPHIC | 120513
39 |  | a202506_ngnecorporatepre033.jpg | GRAPHIC | 90307
40 |  | a202506_ngnecorporatepre034.jpg | GRAPHIC | 90505
41 |  | a202506_ngnecorporatepre035.jpg | GRAPHIC | 82808
42 |  | image_0a.jpg | GRAPHIC | 3474
| Complete submission text file | 0001404644-25-000070.txt |  | 5523140

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ngne-20250630.xsd | EX-101.SCH | 1788
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ngne-20250630_lab.xml | EX-101.LAB | 22548
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ngne-20250630_pre.xml | EX-101.PRE | 13050
52 | EXTRACTED XBRL INSTANCE DOCUMENT | ngne-20250630_htm.xml | XML | 2802

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 251091905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)